color-white-paper-icon-small

New White Paper Released

As companies increasingly add regenerative medicine therapies to their pipelines, they must examine their supply chain. Not only are these fragile materials often irreplaceable, but they are also more at risk. Moreover, because complying with anticipated regulations could take months or more, these companies should also consider taking proactive steps now.

This white paper:

  • Explains why traceability is essential and how to deploy Chain of Compliance™ to trace the equipment and processes used in managing the environmental control of these products.
  • Outlines the sparse, industrywide standards that exist now and the expected regulations for nine areas of compliance.
  • Details seven steps that companies should take now to ensure future compliance.
  • Makes it clear how urgent it is for growing companies to anticipate compliance standards.

Cryoport-COC-WhitePaper_Thumbnail

Download our white paper to learn about taking a proactive approach – or risk falling behind!